These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2523551)

  • 1. [Usefulness of several laboratory tests on prethrombotic status in arterial vascular pathology].
    Arosio E; Lechi C; Pancera P
    Recenti Prog Med; 1989 Jan; 80(1):18-24. PubMed ID: 2523551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-thromboglobulin in diabetes: relationships with blood glucose and fibrinopeptide A.
    Burrows AW
    Horm Metab Res Suppl; 1981; 11():22-5. PubMed ID: 6172350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular markers of hemostatic activation in atherosclerosis: a new concept in diagnostic profiling of endogenous pathophysiologic transition.
    Fareed J; Walenga JM; Baker WH; Hayes A; Hoppensteadt DA
    Semin Thromb Hemost; 1986 Apr; 12(2):102-9. PubMed ID: 2943019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-thromboglobulin levels and atherosclerosis. Its relationship with the presence of risk factors].
    Millán Núñez-Cortés J; Marchena MJ; Lorenzo A; Mangas A; García Rojas JF; García Calzado MC
    Rev Clin Esp; 1992 Feb; 190(3):111-4. PubMed ID: 1532862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
    Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
    Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of specific platelet activation markers with carotid arterial wall thickness.
    Ghaddar HB; Cortes J; Salomaa V; Kark JD; Davis CE; Folsom AR; Heiss G; Stinson V; Wu KK
    Thromb Haemost; 1995 Sep; 74(3):943-8. PubMed ID: 8571326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically?
    Gershlick AH
    Circulation; 1990 Jan; 81(1 Suppl):I28-34; discussion I40-1. PubMed ID: 2136816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical tests on the diagnosis of thrombosis].
    Yamanaka M
    Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
    [No Abstract]   [Full Text] [Related]  

  • 10. Markers of thrombotic activity in arterial disease.
    Donaldson MC; Matthews ET; Hadjimichael J; Rickles FR
    Arch Surg; 1987 Aug; 122(8):897-900. PubMed ID: 2957982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological manifestations of a prethrombotic state in developmental Crohn's disease].
    Chamouard P; Grunebaum L; Duclos B; Wiesel L; Cazenave JP
    Gastroenterol Clin Biol; 1990; 14(3):203-8. PubMed ID: 2188861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
    Artery; 1980; 8(1):73-9. PubMed ID: 6158934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of thrombotic risk in type 2 diabetes: determination of platelet factor 4 and beta thromboglobulin].
    Diop S; Ka-Cisse M; Toure-Fall AO; Diagne Fall-Sarr F; Diop SN; Thiam D; Diakhate L
    Dakar Med; 2002; 47(2):247-51. PubMed ID: 15776686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies.
    Papp AC; Hatzakis H; Bracey A; Wu KK
    Thromb Haemost; 1989 Feb; 61(1):15-9. PubMed ID: 2526384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of fibrinogen in arterial vascular pathology].
    Colorio CC; Falcón CR; Carreras LO
    Sangre (Barc); 1997 Feb; 42(1):47-52. PubMed ID: 9097719
    [No Abstract]   [Full Text] [Related]  

  • 16. The application of polyethylene glycol to radioimmunoassays used in haemostasis.
    Woodhams BJ; Kernoff PB
    Thromb Res; 1983 Feb; 29(3):333-41. PubMed ID: 6189241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical localization of fibrinogen, platelet factor 4, and beta thromboglobulin in thin frozen sections of human blood platelets.
    Sander HJ; Slot JW; Bouma BN; Bolhuis PA; Pepper DS; Sixma JJ
    J Clin Invest; 1983 Oct; 72(4):1277-87. PubMed ID: 6195190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of thromboembolic diseases: what to do now that the radioimmunoassay has arrived.
    Handin RI
    West J Med; 1981 Jul; 135(1):50-1. PubMed ID: 6455013
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.